| Announce Date | 11/06/2025 |
| EPS Normalized Actual | $0.28 (Beat by $0.11) |
| EPS GAAP Actual | $0.28 (Beat by $0.11) |
| Revenue Actual | $0.3059B |
| Revenue Surprise | Beat by $305.9M |
| Announce Date | 10/01/2025 (Pre-Market) |
| EPS Normalized Estimate | $0.6 |
| EPS GAAP Estimate | $0.6 |
| Revenue Estimate | $0.38025B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2027 | 1.92 | 9.51 | 1.87133 | 1.97144 | 1 |
| Dec 2026 | 1.63 | 11.2 | 1.59026 | 1.66039 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0 | -0.63 | 0.3059B | 25.73% | -81.6M |
| FQ2 2025 (Jun 2025) | 0.0881 | -0.5419 | 0.3046B | 3.25% | -81.4M |
| FQ1 2025 (Mar 2025) | 0.03 | -0.35 | 0.2805B | 100% | -35.8M |
| FQ4 2024 (Dec 2024) | -0.49 | -0.49 | 0.2405B | 100% | 240.5M |
| FQ3 2024 (Sep 2024) | -0.135 | -0.135 | 0.2272B | 100% | 227.2M |
| FQ2 2024 (Jun 2024) | 0.1 | 0.1 | 0.2947B | 100% | 294.7M |
| FQ1 2013 (Mar 2013) | 0 | 0 | 0.3463B | 100% | 346.3M |
| FQ2 2013 (Jun 2013) | 0.55 | 0.55 | 0.3541B | 100% | 354.1M |
FQ4 Announce Date
10/01/2025 (Pre-Market)
Consensus EPS Estimates
0.6
Consensus Revenue Estimates
0.38025B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.52 | -- | 0.49619 | 0.54585 | 1 |
| FQ3 2027 (Sep 2027) | 0.55 | -- | 0.55 | 0.55 | 1 |
| FQ2 2027 (Jun 2027) | 0.49 | -- | 0.49 | 0.49 | 1 |
| FQ1 2027 (Mar 2027) | 0.47 | -- | 0.44848 | 0.49337 | 1 |
| FQ4 2026 (Dec 2026) | 0.47 | -- | 0.47 | 0.47 | 1 |
| FQ3 2026 (Sep 2026) | 0.49 | -- | 0.49 | 0.49 | 1 |
| FQ2 2026 (Jun 2026) | 0.41 | 78.51 | 0.41 | 0.41 | 1 |
| FQ1 2026 (Mar 2026) | 0.26 | 88.46 | 0.26 | 0.26 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.38B | -- | 0.37B | 0.4B | 1 |
| FQ3 2027 (Sep 2027) | 0.37B | -- | 0.37B | 0.37B | 2 |
| FQ2 2027 (Jun 2027) | 0.36B | -- | 0.36B | 0.36B | 2 |
| FQ1 2027 (Mar 2027) | 0.36B | -- | 0.35B | 0.38B | 1 |
| FQ4 2026 (Dec 2026) | 0.26B | -- | 0.26B | 0.26B | 1 |
| FQ3 2026 (Sep 2026) | 0.26B | -18.48 | 0.26B | 0.26B | 1 |
| FQ2 2026 (Jun 2026) | 0.25B | -19.88 | 0.25B | 0.25B | 1 |
| FQ1 2026 (Mar 2026) | 0.25B | -12.17 | 0.25B | 0.25B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
2
EPS # of Misses
5
EPS # of in-lines
1
Revenue # of Beats
5
Revenue # of Misses
3
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.63 | 0 | -0.63 | -INF% |
| FQ2 2025 (Jun 2025) | 0.63 | 0.0881 | -0.5419 | -615.1% |
| FQ1 2025 (Mar 2025) | 0.38 | 0.03 | -0.35 | -1166.67% |
| FQ4 2024 (Dec 2024) | -0.49 | -0.49 | 100% | |
| FQ3 2024 (Sep 2024) | -0.135 | -0.135 | 100% | |
| FQ2 2024 (Jun 2024) | 0.1 | 0.1 | 100% | |
| FQ1 2013 (Mar 2013) | 0 | 0 | NAN% | |
| FQ2 2013 (Jun 2013) | 0.55 | 0.55 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0.39B | $0.31B | $-81.6M | -26.68% |
| FQ2 2025 (Jun 2025) | $0.39B | $0.3B | $-81.4M | -26.72% |
| FQ1 2025 (Mar 2025) | $0.32B | $0.28B | $-35.8M | -12.76% |
| FQ4 2024 (Dec 2024) | $0B | $0.24B | $240.5M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $0.23B | $227.2M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $0.29B | $294.7M | 100% |
| FQ1 2013 (Mar 2013) | $0B | $0.35B | $346.3M | 100% |
| FQ2 2013 (Jun 2013) | $0B | $0.35B | $354.1M | 100% |